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Abstract
Background: The clinical value of the controlling nutritional status (CONUT) score in hepatocellular carcinoma
(HCC) has increased. The aim of this meta-analysis was to systematically review the association between the CONUT
score and outcomes in patients undergoing hepatectomy for HCC.
Methods: Embase, Medline Ovid, Web of Science, Cochrane CENTRAL, and Google Scholar were systematically
searched. Random effects meta-analyses were conducted to examine the prognostic value of the CONUT score in
HCC patients.
Results: A total of five studies including 4679 patients were found to be eligible and analyzed in the meta-analysis.
The CONUT score was significantly associated with overall survival (HR 1.78, 95%CI = 1.20–2.64, P = 0.004, I2 = 79%),
recurrence-free survival (HR 1.34, 95%CI = 1.17–1.53, P < 0.001, I2 = 16%) and postoperative major complications
(OR 1.85, 95%CI: 1.19–2.87, P = 0.006, I2 = 72%) in HCC patients. Moreover, the CONUT score was associated with the
Child–Pugh classification, liver cirrhosis, ICGR15, and tumor differentiation. However, it was not associated with
tumor size, tumor number, and microvascular invasion.
Conclusions: The CONUT score is an independent prognostic indicator of the prognosis and is associated with
postoperative major complications and hepatic functional reserve in HCC patients.
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Background
Hepatocellular carcinoma is a major cause of cancer-
related morbidity and mortality [1]. Despite advances in
early diagnosis and personalized medicine, the clinical
outcome of hepatocellular carcinoma (HCC) remains
poor with high recurrence rate after curative treatment
[2]. Therefore, the identification of accurate and reliable
prognostic markers is necessary in HCC patients.
The controlling nutritional status (CONUT) score [3],
calculated from serum albumin level, total cholesterol
level, and total lymphocyte count, was originally devel-
oped as a nutritional assessment tool in Western Europe
in 2005. The evidence regarding the influence of the
CONUT score on prognosis in gastrointestinal cancers
has been growing, particularly in Asian populations [4,
5]. We have recently reported on the association be-
tween the CONUT score and postoperative complication
risk in gastrointestinal and hepato-pancreato-biliary
surgical oncology [6]. However, to the best of our know-
ledge, no study has systematically investigated the
significance of the CONUT score on outcomes in pa-
tients with HCC. Surgical complication risk and cancer
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prognosis differ between cancers and procedures. There-
fore the effect of the CONUT score in patients with spe-
cific cancers should be systematically examined separately.
We herein conducted this systematic review and meta-
analysis to evaluate the association between preoperative
CONUT score and outcomes in patients undergoing
hepatectomy for HCC. Furthermore, the impact of the
CONUT score on clinicopathological factors was identi-
fied score in HCC patients.
Methods
Search methodology
A systematic literature search was performed on July 4th
2019 in 5 publication repositories: Embase, Medline
Ovid, Web of Science, Cochrane CENTRAL, and Google
scholar. The full search for all repositories is appended
to this article (Additional file 1: Table S1). The methods
for developing our search have been detailed in a previ-
ous publication [6]. This study is reported according to
the Preferred Reporting Items for Systematic Reviewers
and Meta-Analyses (PRISMA) guidelines [7].
Criteria for the review
Inclusion criteria were the following: original article, pa-
tients undergoing hepatectomy for HCC; the preopera-
tive assessment of the CONUT score; and reported
postoperative outcomes. In the case of multiple publica-
tions by the same institute, the study focusing on long-
term outcomes or the study with the last date of publi-
cation was included in the meta-analyses.
Titles, abstracts and full articles were screened inde-
pendently by two investigators (KT and PD), according
to the PRISMA guidelines. All original articles that met
the criteria were included. From the included articles,
year and country of study publication, study type, patient
information, cut-off and prevalence of the CONUT
score, and postoperative short-term and long-term out-
comes were extracted. The methodological quality of
each studies was evaluated based on the Newcastle-
Ottawa quality assessment scale for cohort studies [8].
Studies with a total score with 6 or higher were consid-
ered high-quality studies [9].
The primary outcomes were overall survival (OS), de-
fined as time from surgery to death or last follow-up,
and recurrence-free survival (RFS), defined as time from
surgery to recurrence or last follow-up/death. Secondary
outcomes were postoperative complications and the clin-
icopathological parameters. Postoperative complications
were graded based on the Clavien–Dindo classification
(CDc) [10], with major complications defined as CDc
≥3. The clinicopathological parameters included the
Child–Pugh classification (A versus B), the degree of
liver cirrhosis, indocyanine green retention test after 15
min (ICGR15), and tumor characteristics (tumor size,
tumor number [single versus multiple], tumor differenti-
ation [well and moderate differentiated versus poorly dif-
ferentiated], and microvascular invasion).
Statistical analysis
Random effects meta-analyses were conducted to esti-
mate the average correlation of the CONUT score with
OS and RFS. Random effects models were used, as the
populations were heterogeneous and consisted of pa-
tients deriving from different countries and undergoing
different treatment protocols. The pooled hazard ratio
(HR) with 95% confidence interval (95%CI) and the
mean difference (MD) for continuous variables with
95%CI were calculated using the inverse variance
method. The pooled odds ratio (OR) for dichotomous
variables was calculated using the Mantel-Haenszel
method. Heterogeneity among studies was quantified by
calculating the I2 values and the Chi-square test, with
P < 0.05 being statistically significant and I2 values of
50% or more indicating the presence of heterogeneity.
Potential publication bias for outcomes was examined
using Funnel plots. Analyses were conducted using R
3.5.4 (cran.r-project.org) and Review Manager 5.3
(Cochrane Collaboration, 2014).
Results
Characteristics of included studies
From 366 retrieved clinical records, seven articles met
the inclusion criteria (Fig. 1) [11–17]. All included stud-
ies were retrospective series from Asian countries, more
specifically Japan and China (Table 1). There were six
single center studies [11–13, 15–17] and one multi-
center study [14]. Regarding the cut-off value of the
CONUT score, six studies used preoperative CONUT
score with the following cut-off values: CONUT ≤1 vs
CONUT ≥2 in one study [17], CONUT ≤2 vs CONUT
≥3 in two studies [11, 16], and CONUT ≤3 vs CONUT
≥4 in two studies [12, 14], and CONUT ≤4 vs CONUT
≥5 in one study [13]. While postoperative CONUT score
was used in one study with the cut-off value of CONUT
≤7 vs CONUT ≥8 [15]. The prevalence in patients with
high CONUT score ranged between 19 and 49%. Five
studies [11, 12, 14, 16, 17] focused on long-term out-
come as primary endpoints, and two studies [13, 16] fo-
cused on short-term outcome. The quality assessment of
the included studies found that all studies were consid-
ered to be of high-quality with a score of 6 or higher
based on the Newcastle-Ottawa quality scale (details
shown in Additional file 1: Table S2).
Reported outcomes
The literatures reporting the effects of the CONUT
score on outcome in patients undergoing hepatectomy
for HCC are summarized in Table 2.
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Five studies reported data on OS and RFS [11, 12, 14,
16, 17]. The Kaplan-Meier curve showed that patients
with preoperative high CONUT score had a significantly
poorer prognosis in terms of OS and RFS than those
with low CONUT score in all studies. In the multivari-
able analyses, preoperative CONUT score was identified
as an independent predictor associated with OS in all
five studies. Regarding RFS, three studies [11, 14, 16]
showed a significant association between preoperative
CONUT score and RFS in the multivariable analysis,
whereas two studies [12, 17] showed no significant
association.
All studies reported data on postoperative complica-
tions including major complications in five studies [11–
14, 16], overall complications in three studies [13, 16,
17] and mortality in two studies [13, 15]. Takagi et al.
[11, 13] showed no significant association between pre-
operative CONUT score and overall and major complica-
tions, but found the preoperative CONUT score to be
associated with an increased risk of mortality after hepa-
tectomy (OR 9.41, 95%CI = 1.15–77.4, P = 0.038). In
addition, a higher CONUT score was related to the inci-
dence of postoperative ascites, posthepatectomy liver fail-
ure, sepsis and enteritis. Harimoto et al. [14] reported
significant differences between the groups in terms of
major complications based on multi-center analysis (low
CONUT: 11.0% vs. high CONUT: 17.7%; P < 0.01). Li
et al. [15] demonstrated that early postoperative CONUT
score was independently associated with major complica-
tions (OR 2.05, 95% CI = 1.37–3.01, P < 0.001). The
CONUT score was also associated with postoperative pul-
monary complications, bile leakage, intra-abdominal
hemorrhage and posthepatectomy liver failure (grade C).
Wang et al. [16] showed significant differences between
the groups in overall complications (low: 59.3% vs. high:
74.3%; P = 0.029), however Lin et al. [17] found no signifi-
cant differences in overall complications (low: 23.3% vs.
high: 29.4%; P = 0.177).
Data on hepatic functional reserve and pathological
findings including the degree of hepatic cirrhosis were
examined in three studies [11, 12, 14]. Takagi (2017)
et al. [11] reported that the CONUT score was
Fig. 1 PRISMA 2009 Flow Diagram
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significantly associated with platelet count (normal nutrition:
19.7 × 104/μL vs. light undernutrition: 16.9 × 104/μL vs. mod-
erate undernutrition: 18.0 × 104/μL; P= 0.003), prothrombin
time (normal: 104% vs. light: 96% vs. moderate: 90%; P <
0.001), Child–Pugh classification grade B (normal: 2.4% vs.
light: 0.6% vs. moderate: 5.4%; P= 0.01), technetium-99m-
galactosyl human serum albumin, and the hepatic cirrhosis
(normal: 39% vs. light: 51% vs. moderate: 66%; P= 0.017).
Harimoto (2017) et al. [12] found the significant association
between the CONUT score and prothrombin time (low
CONUT: 90% vs. high CONUT: 83%; P < 0.01), the Child–
Pugh classification grade B (low: 4% vs. high: 26%; P < 0.01),
and liver damage grade B (low: 13% vs. high: 50%; P < 0.01),
but no association with ICGR15 (low: 14% vs. high: 16%; P=
0.12), hepatic cirrhosis (low: 41% vs. high: 52%; P= 0.11), and
tumor characteristics. Harimoto (2018) et al. [14]
Table 1 Literatures of the effects of the CONUT score in patients undergoing hepatectomy for hepatocellular carcinoma
Study Year Country Study design Number
(Male)
Tumor stage Cut-off for high
CONUT group
Prevalence of high
CONUT score
End points Qualitya
Takagi et al. [11] 2017 Japan Retrospective
Single center
295 (241) I: 36
II: 126
III: 92
IV: 41
≥3 40.0% OS
RFS
7
Harimoto et al. [12] 2017 Japan Retrospective
Single center
357 (270) I: 58
II: 187
III: 93
IV: 19
≥4 19.3% OS
RFS
6
Takagi et al. [13] 2018 Japan Retrospective
Single center
331 (269) I + II: 185
III + IV: 146
≥5 9.1% Complications 6
Harimoto et al. [14] 2018 Japan Retrospective
Multi-center
2461 (1785) I + II: 1437
III + IV: 1024
≥4 21.9% OS
RFS
6
Li et al. [15] 2018 China Retrospective
Single center
1334 (1136) n.a. ≥8b 49.4% Complications 8
Wang et al. [16] 2018 China Retrospective
Single center
209 (172) BCLC stage A: 126
B: 40
C: 43
≥3 34.5% OS
RFS
PHR
6
Lin et al. [17] 2019 China Retrospective
Single center
380 (333) I + II: 304
III + IV: 76
≥2 49.2% OS
RFS
8
aScore from a maximum of 9 evaluated by the Newcastle–Ottawa quality assessment scale for cohort studies [8].
bEvaluated by postoperative CONUT score
CONUT controlling nutritional status, OS overall survival, RFS recurrence-free survival, n.a not available, BCLC stage Barcelona clinic liver cancer stage, PHR
postoperative hepatitis B virus reactivation
Table 2 Literatures reporting the effects of the CONUT score on postoperative outcome in patients undergoing hepatectomy for
hepatocellular carcinoma
Study Complications Mortality Recurrence-free survival Overall survival
Takagi et al. [11] Major (CDc≥ III):
15 vs 14% (P = 0.79)
n.a. 5-year: 27.9 vs 41.4% (P = 0.011)
HR 1.64 (1.15–2.30), P = 0.006a
5-year: 61.9 vs 74.9% (P = 0.006)
HR 2.50 (1.47–4.23), P = 0.001a
Harimoto et al. [12] Major (CDc≥ III):
20.3 vs 14.9% (P = 0.36)
n.a. 5-year: 8.8 vs 38.0% (P < 0.01)
HR 1.51 (1.06–2.15), P = 0.02b
5-year: 47.6 vs 78.0% (P < 0.01)
HR 2.16 (1.25–3.72), P = 0.03a
Takagi et al. [13] Overall (CDc≥ II):
56.7 vs 45.5% (P = 0.24)
Major (CDc≥ III):
23.3 vs 13.6% (P = 0.15)
10.0 vs 1.3%
(P = 0.002)
OR 9.41 (1.15–77.4), P = 0.038a
n.a. n.a.
Harimoto et al. [14] Major (CDc≥ III):
17.7 vs 11.0% (P < 0.01)
n.a. HR 1.219 (1.06–1.40), P = 0.006a HR 1.223 (1.06–1.41), P = 0.006a
Li et al. [15] Major (CDc≥ III):
15.6 vs 6.2% (P < 0.001)
OR 2.05 (1.37–3.01), P < 0.001a
2.6 vs 0.4%
(P = 0.001)
n.a. n.a.
Wang et al. [16] Overall:
74.3 vs 59.3% (P = 0.029)
n.a. 5-year: 10.0 vs 9.6% (P = 0.001)
HR 1.54 (1.10–2.16), P = 0.011a
5-year: 31.3 vs 44.0% (P < 0.001)
HR 1.62 (1.05–2.51), P = 0.03a
Lin et al. [17] Overall (CDc≥ II):
29.4 vs 23.3% (P = 0.177)
n.a. 5-year: 37.2 vs 47.6% (P = 0.016)
HR 1.36 (1.00–1.85), P = 0.052a
5-year: 66.7 vs 82.8% (P < 0.001)
HR 2.40 (1.74–4.25), P = 0.001a
Data are shown for high CONUT group versus low CONUT group. Odds ratio (OR) and Hazard ration (HR) is shown with 95% confidence interval. aMultivariable
analysis. bUnivariate analysis
CONUT controlling nutritional status, CDc Clavien–Dindo classification, n.a not available
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demonstrated significant differences regarding total bilirubin
(low: 0.79mg/dl vs. high: 0.84mg/dl; P < 0.01), prothrombin
time (low: 93% vs. high: 85%; P < 0.01), ICGR15 (low: 15% vs.
high: 20%; P < 0.01), the Child–Pugh classification grade B
(low: 2% vs. high: 22%; P < 0.01), and hepatic cirrhosis (low:
47% vs. high: 64%; P < 0.01), however no differences regard-
ing tumor characteristics. Li et al. [15] showed no differences
of Child–Pugh classification grade B (low: 2.5% vs. high:
3.3%; P= 0.37), tumor characteristics, but hepatic cirrhosis
(low: 54% vs. high: 64%; P < 0.001). Wang et al. [16] investi-
gated the effect of the CONUT score in predicting postoper-
ative hepatitis B reactivation (PHR). They found that the
incidence of PHR was significantly higher in patients with
high CONUT score (low: 5% vs. high: 32%; P < 0.001) and
the CONUT score was strongly associated with PHR (HR
7.66, 95%CI: 2.47–23.8, P < 0.001) in the logistic regression
model. Lin et al. [17] constructed the nomogram including
the CONUT score, liver cirrhosis, tumor size and differenti-
ation as prognostic variables. They reported the CONUT-
based nomogram (the C-index 0.71, 95%CI: 0.65–0.77) had
superior discriminative ability to predict overall survival com-
pared with conventional staging systems such as the BCLC
stage (the C-index 0.63, 95% CI: 0.58–0.68), the TNM classi-
fication (the C-index 0.59, 95% CI: 0.53–0.64), and the CLIP
score (the C-index 0.58, 95% CI: 0.53–0.64).
Meta-analysis
From seven studies included in the systematic review, two
articles were excluded in the meta-analysis as duplicate
data from the same institute was reported. Accordingly,
five articles with 4679 patients were included in the meta-
analysis [11, 14–17].
Based on four studies including 3345 patients [11, 14,
16, 17], patients with high CONUT score had a signifi-
cantly worse OS and RFS compared with those with low
CONUT score (OS: HR 1.78, 95%CI = 1.20–2.64, P =
0.004, I2 = 79%, P < 0.01; RFS: HR 1.34, 95%CI = 1.17–
1.53, P < 0.001, I2 = 16%, P = 0.31), as shown in Fig. 2. A
significant heterogeneity was found across the studies
with respect to OS. Funnel plots of OS and RFS are
demonstrated in Additional file 1: Figure S1.
Figure 3 shows results of the meta-analyses for the
secondary outcomes in terms of high CONUT group
versus low CONUT group. Meta-analyses showed that
the CONUT score was associated with the incidence
of postoperative major complications (OR 1.85, 95%
CI: 1.19–2.87, P = 0.006, I2 = 72%, P = 0.03), the
Child–Pugh classification B (OR 6.12, 95% CI: 1.88–
20.0, P = 0.003, I2 = 92%, P < 0.001, liver cirrhosis (OR
1.89, 95% CI: 1.51–2.35, P < 0.001, I2 = 46%, P = 0.13),
and ICGR15 (MD 4.21, 95%CI: 3.21–5.21, P < 0.001,
I2 = 0%, P = 0.54). Regarding tumor characteristics, the
CONUT score was associated with tumor differenti-
ation (OR 1.24, 95% CI: 1.06–1.46, P = 0.008, I2 = 0%,
P = 0.97). However, no significant association was
found in tumor size (MD 0.17, 95% CI: − 0.05–0.38,
P = 0.12, I2 = 0%, P = 0.85), tumor number (OR 1.15,
95% CI: 0.97–1.38, P = 0.12, I2 = 11%, P = 0.34), and
microvascular invasion (OR 1.11, 95% CI: 0.96–1.29,
P = 0.16, I2 = 0%, P = 0.75).
a
b
Fig. 2 Forest plots demonstrating primary outcomes in terms of high CONUT group versus low CONUT group. a Overall survival; and (b)
Recurrence-free survival
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Discussion
This systematic review and meta-analysis investigated
the prognostic value of the CONUT score in patients
undergoing hepatectomy for HCC. The present study
demonstrated that the CONUT score was associated
with OS, RFS and the incidence of postoperative major
complications in patients with HCC. Moreover, we
found that the CONUT score was associated with the
Child–Pugh classification, liver cirrhosis, ICGR15, and
tumor differentiation, whereas it was not associated with
tumor size, tumor number, and microvascular invasion.
Recent meta-analyses have shown that the nutritional
status evaluated by the CONUT score and the prognos-
tic nutritional index (PNI) was associated with prognosis
of various cancers [4, 5, 18]. Regarding the prognostic
value of such nutritional assessment tools in HCC pa-
tients, recent meta-analyses have reported the relation-
ship between the PNI and prognosis [9, 19]. However,
the CONUT score has been reported to provide the
most appropriate sensitivity and specificity in patients
with HCC compared with other immune-nutritional pa-
rameters including the PNI [15, 17]. To date, the effect
of the CONUT score on prognosis in patients with HCC
has not been examined systematically. Actually, previous
studies on the CONUT score in HCC patients reported
different outcomes in terms of RFS and postoperative
complications, as is shown in Table 2. Therefore, our re-
sults would add the clinical evidence of the association
between the CONUT score and outcome in patients
with HCC.
The present meta-analysis indicates that the CONUT
score is associated with the prognosis, the postoperative
major complications and hepatic functional reserve in
HCC patients. Patients with high CONUT score had a
significantly worse OS and RFS, and had a higher inci-
dence of postoperative major complications than those
with low CONUT score in HCC patients after hepatec-
tomy. These results are in line with discovered correla-
tions between nutritional status markers like PNI and
sarcopenia, and the prognosis and postoperative com-
plications in gastrointestinal and hepatopancreatobili-
ary surgical oncology [18, 20, 21]. In addition, it
should be noted that prognosis in patients with HCC
depends on tumor stage as well as hepatic functional
reserve [22, 23]. Indeed, our meta-analysis demon-
strated the relationship between the CONUT score
and the Child–Pugh classification, liver cirrhosis, and
ICGR15. Interestingly, Wang et al. reported that the
CONUT score is an effective indicator predicting PHR
in hepatitis B HCC patients [16]. Among tumor
Fig. 3 Forest plots demonstrating secondary outcomes in terms of high CONUT group versus low CONUT group. a Major complications
(CDc≥ III); (b) Child-Pugh B; (c) Liver cirrhosis; (d) ICGR15; (e) Tumor size; (f) Tumor number (multiple); (g) Poor differentiation; and (h)
Microvascular invasion
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characteristics, tumor differentiation was the only
pathological feature associated with the CONUT
score.
The biological mechanism explaining the correlation
between the CONUT score and short- and long-term
outcomes is unknown. In past studies, preoperative
higher CONUT score was found to be associated with
worse nutritional status as well as poorer immune func-
tional status preoperatively [16]. In addition, postopera-
tive immune functional status was worse in patients
with preoperative higher CONUT score. Perioperative
poor immune-nutritional status could in turn be related
to a higher incidence of postoperative complications.
Separate CONUT score parameters have been correlated
with outcomes in HCC patients in past studies. Serum
albumin, on itself a major indicator of nutritional status,
is associated with prognosis and complication risk in pa-
tients following hepatectomy for HCC [24, 25]. Total
lymphocyte count is a surrogate marker of immune-
nutritional status in cellular and antiviral immunity and
has been shown to correlate with prognosis [26, 27].
Serum cholesterol level, reflecting a malnutritional and
end stage liver function status, is a prognostic factor to
predict postoperative HCC recurrence and OS in HCC
patients as well [28].
Several limitations of the present study should be ac-
knowledged. All the included studies were retrospective
studies from Japan and China, using different cut-off
values for the CONUT score, and with the different preva-
lence in patients with high CONUT score ranging from 9
to 49%. The number of included studies in the meta-
analysis was small. Therefore, further studies are needed
to identify the significance of the CONUT score and de-
termine the most appropriate cut-off value to estimate the
prognosis and complication risks in HCC patients.
Conclusions
The present study suggests that the CONUT score could
be an indicator to predict the prognosis, postoperative
complications and hepatic functional reserve in patients
following hepatectomy for HCC.
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